Suppr超能文献

非透析慢性肾脏病中的顽固性高血压

Resistant hypertension in nondialysis chronic kidney disease.

作者信息

Borrelli Silvio, De Nicola Luca, Stanzione Giovanna, Conte Giuseppe, Minutolo Roberto

机构信息

Division of Nephrology, Second University of Naples, 80125 Naples, Italy.

出版信息

Int J Hypertens. 2013;2013:929183. doi: 10.1155/2013/929183. Epub 2013 Apr 22.

Abstract

Resistant hypertension (RH) is defined as blood pressure (BP) that remains above the target of less than 140/90 mmHg in the general population and 130/80 mmHg in people with diabetes mellitus or chronic kidney disease (CKD) in spite of the use of at least three full-dose antihypertensive drugs including a diuretic or as BP that reaches the target by means of four or more drugs. In CKD, RH is a common condition due to a combination of factors including sodium retention, increased activity of the renin-angiotensin system, and enhanced activity of the sympathetic nervous system. Before defining the hypertensive patient as resistant it is mandatory to exclude the so-called "pseudoresistance." This condition, which refers to the apparent failure to reach BP target in spite of an appropriate antihypertensive treatment, is mainly caused by white coat hypertension that is prevalent (30%) in CKD patients. Recently we have demonstrated that "true" RH represents an independent risk factor for renal and cardiovascular outcomes in CKD patients.

摘要

顽固性高血压(RH)的定义为:尽管使用了至少三种包括利尿剂在内的全剂量抗高血压药物,普通人群血压仍高于140/90 mmHg的目标值,糖尿病或慢性肾脏病(CKD)患者血压仍高于130/80 mmHg的目标值;或者血压通过四种或更多药物才能达到目标值。在CKD患者中,由于钠潴留、肾素-血管紧张素系统活性增加以及交感神经系统活性增强等多种因素共同作用,RH很常见。在将高血压患者定义为顽固性高血压之前,必须排除所谓的“假性顽固性高血压”。这种情况是指尽管进行了适当的抗高血压治疗,但血压仍明显未达到目标值,主要由白大衣高血压引起,而白大衣高血压在CKD患者中很常见(占30%)。最近我们已经证明,“真正的”RH是CKD患者发生肾脏和心血管不良结局的独立危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8609/3654372/40d629b1bac3/IJHT2013-929183.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验